Ridinilazole Well-Tolerated, Yields Sustained Clinical Response In Patients With CDI, Trial Shows

Healio (10/20, Stulpin) reports, “Nearly three out of every four patients with Clostridioides difficile infection [CDI] being treated with ridinilazole had a sustained clinical response, according to data” from a “global, double-blinded, randomized phase...